| Document |
Document Title |
|
WO/2016/054687A1 |
The present invention relates to a sutureless method of repairing soft tissue defects in soft tissue including ligaments such as anterior cruciate ligaments (ACLs). Jn particular, the present invention relates a sutureless method of repa...
|
|
WO/2016/056901A1 |
The invention provides a process of preparing an adhesive haemostatic product, said process comprising the steps of: providing a porous solid substrate; coating the substrate with a coating liquid that comprises an electrophilically acti...
|
|
WO/2016/053829A1 |
Porous devices are provided that include a particle-containing fibrous porous matrix and a fluid absorbed in the particle-containing porous fibrous nonwoven matrix. The particle-containing fibrous porous matrix includes a porous fibrous ...
|
|
WO/2016/053875A1 |
Medical dressings and methods of using same. The medical dressing can include a fluid management article. The fluid management article can include a fibrous substrate and porous polymeric particles. At least 50% of the porous polymeric p...
|
|
WO/2016/049765A1 |
A process for manufacturing particles of water-absorbing material is provided. The process includes providing a powder bed composed of an absorptive powder comprising a water-absorbing polysaccharide onto a surface; releasing an aqueous ...
|
|
WO/2016/047981A1 |
The present invention relates to a wound dressing composition and a wound dressing material. The present invention is excellent in terms of the sustained-release property of an antimicrobial material, as well as wound healing effect, and...
|
|
WO/2016/042406A1 |
A heterostructure for a dressing material includes a substrate; and a dehydrated active ingredient deposited on the substrate in a deactivated state. The dehydrated active ingredient is configured to return to an activated state when the...
|
|
WO/2016/041067A1 |
The present disclosure relates to emissive polymeric matrices and methods of using them. The emissive polymeric matrices comprise a monomer such as, for example, 2- hydroxyehtyl methacrylate (HEMA) and at least one chromophore.
|
|
WO/2016/041443A1 |
Provided is a biocompatible hemostatic product or tissue sealing agent, comprising polyoxyethylene particles; the viscosity-average molecular weight of the polyoxyethylene is 100,000 daltons to 7,000,000 daltons; and the polyoxyethylene ...
|
|
WO/2016/044844A1 |
The invention provides compounds, compositions, and methods to improve or accelerate the healing of a wound. In various embodiments, the methods can include the topical treatment of the wound with the enzyme MMP-8, or the topical treatme...
|
|
WO/2016/042471A1 |
The present invention relates to a material comprising or consisting in chitin nanofibrils, lignin and at least a co-polymer, as well as to a process for the preparation thereof. Furthermore, the present invention relates to biomedical a...
|
|
WO/2016/042474A1 |
The present invention relates to a material comprising or consisting in chitin nanofibrils, lignin and at least a co-polymer, as well as to a process for the preparation thereof. Furthermore, the present invention relates to biomedical a...
|
|
WO/2016/040495A1 |
This invention claims disposable garments comprising a stretchy laminate and methods of making the same.
|
|
WO/2016/038109A1 |
A medical dressing (1;20) is disclosed, comprising a substrate(2)comprising a first chemical compound,said substrate having a first surface (4),wherein said medical dressing further comprises an adhesive layer(3)having a skin-facing surf...
|
|
WO/2016/040474A1 |
This invention claims hot melt adhesive compositions that can be used to form elastic composites that are useful in disposable absorbent articles. The compositions have good elastic recovery and high peel adhesion at a viscosity of less ...
|
|
WO/2016/038289A1 |
The invention relates to a material comprising at least one electronegative fibre having a negative charge density of between 0.01 and 5 mmol/g and a liquid absorption capacity of less than 9.5 g of physiological serum per gramme of fibr...
|
|
WO/2016/038287A1 |
The invention relates to a material comprising at least one electronegative fibre having a negative charge density of between 0.01 and 5 mmol/g and a liquid absorption capacity of between 10 and 20 g of physiological serum per gramme of ...
|
|
WO/2016/040483A1 |
This invention claims a disposable article including at least two bonded regions, one of the regions has elastic properties; the other region is different from the first.
|
|
WO/2016/038111A1 |
A medical dressing (30) is disclosed, comprising an adhesive layer (3) having skin-facing surface (6) to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within...
|
|
WO/2016/035232A1 |
The present invention is a film-forming composition comprising a polymer obtained by polymerizing: (A) 5-80 mass% of a silicone resin which has R3SiO1/2, R2R'SiO1/2, and SiO2 units (where R, which may be the same as or different from eac...
|
|
WO/2016/036330A1 |
The present invention relates to a repairing layer which covers at least a part of wound upon being applied inside or onto a wound and comprises water, ozonized oil, glycerol and astragalus plant extract.
|
|
WO/2016/032833A1 |
There is provided an absorbent system for wound care products having a liquid-absorbing, wound-contacting, lower layer and a more highly absorbent upper layer in liquid communication with said lower layer. Liquid communication may be pro...
|
|
WO/2016/029602A1 |
A total absorption dressing for viscous exudate and blood, comprising a sheet-shaped dressing body (1). The dressing body (1) comprises an absorbent fluid-retaining layer (11) having a three-dimensionally interconnected spatial structure...
|
|
WO/2016/029328A1 |
The invention relates to a pharmaceutical composition consisting of snail slime of Helix aspersa müller (Cryptophalus aspersus) (5% to 50%), chamomile extract (5% to 10%), honey (5% to 10%), and additives and/or pharmaceutically accepte...
|
|
WO/2016/033385A1 |
This invention is directed to a multi-layered tissue graft comprising a collagen layer and at least one separated and washed placental tissue component and/or umbilical cord component, wherein the collagen is human collagen substantially...
|
|
WO/2016/028292A1 |
Methods to produce thermoforms from P4HB homopolymer and blends thereof have been developed. These thermoforms are produced from films and sheets including P4HB, wherein the intrinsic viscosity of the P4HB is less than 3.5 dl/g, but grea...
|
|
WO/2016/029103A1 |
Aqueous solutions that include: (A) an organic polyol having from 2 to 20 carbon atoms and having a flash point of at least 93°C; (B) a base; (C) a surfactant; and (D) water, where the aqueous solution does not include an organic solven...
|
|
WO/2016/026028A1 |
Disclosed is a device, system, method and computer readable medium for use with biological and nonbiological data to determine indicators and/or identify trends on an individual or population scale. A reconciled combination of one or mor...
|
|
WO/2016/025293A1 |
Systems, methods, and apparatuses for modulating proteases including matrix metalloproteinase (MMP), elastase, and bacterial protease in a negative pressure therapy system are described. A mesh having a sacrificial substrate is included....
|
|
WO/2016/024720A1 |
The present invention relates to a mobile or portable electrospinning apparatus which can be applied to: life science fields for a delivery body, which delivers a drug to an affected area of a patient, a hemostatic agent, and wound dress...
|
|
WO/2016/025770A1 |
An absorbent wound dressing comprises a hydrophilic porous substrate and polymer- stabilized silver nanoparticles distributed throughout the porous substrate. The silver nanoparticles have a particle size d5o in the range of about 45 nm ...
|
|
WO/2016/022708A1 |
A method of causing delayed hemostasis. A hemostatic product is formed by applying a hemostatic agent to a dextran support. The hemostatic agent is provided with at least one of a reduced concentration and a reduce availability. The hemo...
|
|
WO/2016/020703A1 |
The present invention relates to wound dressings. In particular, the invention relates to antimicrobial wound dressings, methods of making the same and uses of the same. The wound dressing of the present invention comprises a wound conta...
|
|
WO/2016/022795A1 |
A wetness indicating composition is provided, comprising a liquid-activated colorant, a permanent colorant, and a binding matrix.
|
|
WO/2016/020721A1 |
The invention relates to a disposable item of hygiene characterised in that it has a formula that encourages skin care by means of the use of natural compounds such as extract of sugarcane wax, which has pharmacological properties such a...
|
|
WO/2016/020704A1 |
The present invention relates to wound dressings. In particular, the invention relates to antimicrobial wound dressings, methods of making the same and uses of the same. The wound dressing of the present invention comprises a wound conta...
|
|
WO/2016/022504A1 |
An absorbent layer for moderating blood flow from a wound has a non-woven fabric layer of water-insoluble chitosan fibers having a coating of water-absorbent starch on at least one face of the fabric layer. The coating of water-absorbent...
|
|
WO/2016/020306A1 |
It relates to a nonwoven fabric membrane for topical use on the skin, which comprises polymeric nanofibres and an active agent in an amount from 25 to 80%by weight with respect to the total weight of the nonwoven fabric membrane, wherein...
|
|
WO/2016/019085A1 |
Certain embodiments described herein are directed to methods and system that can be used to pressure isolate tissue regions including soft and hard tissues. In some instances, a systemically toxic concentration of an agent can be introdu...
|
|
WO/2016/019279A1 |
Embodiments of the invention include wound packing devices and methods of making and using the same. In an embodiment, the invention includes a wound packing device including a plurality of spacing elements comprising a nanotextured surf...
|
|
WO/2016/014418A1 |
Compositions and methods are provided for enhanced healing of wounds, e.g. cutaneous wounds, by application of a scaffold or matrix, e.g. a hydrogel film comprising a dose of macrophages, or monocyte progenitors thereof, which dose is ef...
|
|
WO/2016/013700A1 |
Provided are a temperature sensitive adhesion prevention composition and a method for producing the same, the composition comprising a polyethylene oxide (PEO) containing copolymer, a carboxy polysaccharide, and a monovalent cation.
|
|
WO/2016/014158A1 |
Disclosed is a resilient foam and methods of making the foam. The resilient foam includes a derivatized polyanionic polysaccharide and has an open-cell structure. When the resilient foam is contacted with water, the foam forms a thixotro...
|
|
WO/2016/010086A1 |
A therapeutic agent for a surface wound, which comprises at least one compound selected from a glycerin alkyl ester represented by formula (I) and a diglycerin alkyl ester represented by formula (II) as an active ingredient.
|
|
WO/2016/010330A1 |
The present invention relates to a polymer foam composition, a method for preparing a polymer foam using the same, and a polymer foam for packing obtained from the same. More specifically, by providing a polymer foam composition capable ...
|
|
WO/2016/009095A1 |
The present invention relates to a textile fabric made from textile fibers which comprises at least one biologically active molecule which is β-endorphin. The present invention also relates to a method for manufacturing the textile fabr...
|
|
WO/2016/011387A1 |
A microporous gel system for certain applications, including biomedical applications, includes an aqueous solution containing plurality of microgel particles including a biodegradable crosslinker. In some aspects, the microgel particles ...
|
|
WO/2016/007776A1 |
Provided are compositions for wound treatment comprising foam impregnated with honey, methods of making such compositions, and methods of treating wounds with such compositions.
|
|
WO/2016/006848A1 |
The present invention relates to a thermoplastic cast which is reusable. The cast according to the present invention comprises: a structure (10) made of a polycaprolactone composite and having a net shape in which polygonal apertures are...
|
|
WO/2016/007692A1 |
A hydrogel composition from a cross-linked polymer derived from one or more olefinically unsaturated polymerizable carboxylic monomers and a thermoplastic polyurethane composition is disclosed. The hydrogel exhibits high yield stress at ...
|
